IL326412A - נוגדנים נגד muc16 ושימושיהם - Google Patents

נוגדנים נגד muc16 ושימושיהם

Info

Publication number
IL326412A
IL326412A IL326412A IL32641226A IL326412A IL 326412 A IL326412 A IL 326412A IL 326412 A IL326412 A IL 326412A IL 32641226 A IL32641226 A IL 32641226A IL 326412 A IL326412 A IL 326412A
Authority
IL
Israel
Prior art keywords
antibodies against
muc16
against muc16
antibodies
Prior art date
Application number
IL326412A
Other languages
English (en)
Inventor
Yifeng Wang
Yaohua Hu
Xia Wang
Zhuozhi Wang
Siwei Nie
Yunying Chen
Jijie Gu
Original Assignee
Wuxi Biologics Ireland Ltd
Yifeng Wang
Yaohua Hu
Xia Wang
Zhuozhi Wang
Siwei Nie
Yunying Chen
Jijie Gu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuxi Biologics Ireland Ltd, Yifeng Wang, Yaohua Hu, Xia Wang, Zhuozhi Wang, Siwei Nie, Yunying Chen, Jijie Gu filed Critical Wuxi Biologics Ireland Ltd
Publication of IL326412A publication Critical patent/IL326412A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3076—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties
    • C07K16/3092—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties against tumour-associated mucins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
IL326412A 2023-08-11 2024-08-09 נוגדנים נגד muc16 ושימושיהם IL326412A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2023112575 2023-08-11
PCT/EP2024/072621 WO2025036848A1 (en) 2023-08-11 2024-08-09 Anti-muc16 antibodies and uses thereof

Publications (1)

Publication Number Publication Date
IL326412A true IL326412A (he) 2026-04-01

Family

ID=92408903

Family Applications (1)

Application Number Title Priority Date Filing Date
IL326412A IL326412A (he) 2023-08-11 2024-08-09 נוגדנים נגד muc16 ושימושיהם

Country Status (3)

Country Link
AU (1) AU2024325109A1 (he)
IL (1) IL326412A (he)
WO (1) WO2025036848A1 (he)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
GB8601597D0 (en) 1986-01-23 1986-02-26 Wilson R H Nucleotide sequences
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
GB8809129D0 (en) 1988-04-18 1988-05-18 Celltech Ltd Recombinant dna methods vectors and host cells
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
EP0402226A1 (en) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformation vectors for yeast yarrowia
US5869619A (en) 1991-12-13 1999-02-09 Xoma Corporation Modified antibody variable domains
DK1621554T4 (da) 1992-08-21 2012-12-17 Univ Bruxelles Immunoglobuliner blottet for lette kæder
GB9325182D0 (en) 1993-12-08 1994-02-09 T Cell Sciences Inc Humanized antibodies or binding proteins thereof specific for t cell subpopulations exhibiting select beta chain variable regions
CU22615A1 (es) 1994-06-30 2000-02-10 Centro Inmunologia Molecular Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos
US6054927A (en) 1999-09-13 2000-04-25 Eaton Corporation Apparatus and method for sensing an object within a monitored zone
US7771951B2 (en) 2001-12-03 2010-08-10 Amgen Fremont Inc. Antibody categorization based on binding characteristics
PL2135881T3 (pl) 2005-06-20 2012-02-29 Genentech Inc Przeciwciała wiążące się z antygenem TAT10772 związanym z nowotworem, do diagnozowania i leczenia nowotworu
CA3255551A1 (en) 2010-03-26 2025-04-15 Memorial Sloan-Kettering Cancer Center MUC16 ANTIBODIES AND METHODS OF USE
CN105722859B (zh) 2013-07-25 2021-05-07 西托姆克斯治疗公司 多特异性抗体、多特异性可活化抗体及其使用方法
JP7066690B2 (ja) 2016-09-23 2022-05-13 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 抗ｍｕｃ１６（ムチン１６）抗体
WO2019148445A1 (en) 2018-02-02 2019-08-08 Adagene Inc. Precision/context-dependent activatable antibodies, and methods of making and using the same

Also Published As

Publication number Publication date
AU2024325109A1 (en) 2026-02-26
WO2025036848A1 (en) 2025-02-20

Similar Documents

Publication Publication Date Title
IL289354A (he) נוגדנים אנטי-154cd ושימושים בהם
EP4085076C0 (en) BCMA-BINDING ANTIBODIES AND THEIR USES
EP4036116A4 (en) ANTI-HIV DOMAIN ANTIBODIES AND USE THEREOF
EP4141030A4 (en) ANTI-CD73 ANTIBODY AND ITS USE
EP4499707A4 (en) CCR8 ANTIBODIES AND THEIR USES
EP4302777A4 (en) ANTI-CLDN6 ANTIBODY AND ITS USE
EP4359442A4 (en) ANTI-CCR8 ANTIBODIES AND THEIR USES
EP3820467A4 (en) ANTIBODY-ALK5 INHIBITOR CONJUGATES AND THEIR USES
EP4142793A4 (en) ABCB5-SPECIFIC ANTIBODIES AND THEIR USES
EP4244255A4 (en) ANTI-TIGIT ANTIBODIES AND THEIR USES
EP4132569A4 (en) ANTI-PHF-TAU ANTIBODIES AND USES
IL291550A (he) נוגדנים אנטי- il-27 ושימושים בהם
EP4053161A4 (en) ANTI-IL-4R SINGLE-DOMAIN ANTIBODY AND ITS USE
IL291546A (he) נוגדנים נגד kir3dl3 ושימושים שלהם
IL291280A (he) נוגדנים כנגד cd371 ושימושיהם
KR20240101546A9 (ko) 항-글리코-lamp1 항체 및 그의 용도
EP4396224A4 (en) Anti-DLL3 Antibodies and Their Uses
LT4288456T (lt) Antikūnai prieš met ir jų panaudojimas
EP4490182A4 (en) Anti-CD36 antibodies and their uses
IL308375A (he) נוגדנים נגד tmprss6 ושימושים בהם
EP4373856A4 (en) ANTI-CLL-1 ANTIBODIES AND THEIR USES
IL286803A (he) נוגדנים כנגד tauc3 ושימושים שלהם
EP4276112A4 (en) Anti-fgfr3 antibody and use thereof
EP4389766A4 (en) ANTI-IGSF1 ANTIBODIES AND THEIR USES
PL4071171T3 (pl) Przeciwciało anty-tm4sf4 i jego zastosowanie